HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002.

Abstract
Serological, epidemiological and molecular aspects of hepatitis C virus (HCV) infection were evaluated in 183 subjects from Londrina, Paraná, Brazil, and adjacent areas. Serum samples which tested anti-HCV positive by microparticle enzyme immunoassay (MEIA) obtained from eight patients with chronic hepatitis C, 48 blood donors, and 127 patients infected with the human immunodeficiency virus (HIV) were submitted to another enzyme immunoassay (ELISA) and to the polymerase chain reaction (PCR). About 78.7% of samples were also reactive by ELISA, with the greater proportion (70.8%) of discordant results verified among blood donors. A similar finding was observed for HCV-RNA detection by PCR, with 111/165 (67.3%) positive samples, with higher rates among HIV-positive subjects and patients with chronic hepatitis than among blood donors. Sixty-one PCR-positive samples were submitted to HCV genotyping, with 77.1, 21.3 and 1.6% of the samples identified as types 1, 3 and 2, respectively. Finally, analysis of some risk factors associated with HCV infection showed that intravenous drug use was the most common risk factor among HIV/HCV co-infected patients, while blood transfusion was the most important risk factor in the group without HIV infection. The present study contributed to the knowledge regarding risk factors associated with HCV infection and the distribution of HCV genotypes in the population evaluated.
AuthorsIngridt Hildegard Vogler, Anna Nishiya, Helena Kaminami Morimoto, Edna Maria Vissoci Reiche, André Luiz Bortoliero, Tiemi Matsuo, Ester Cerdeira Sabino, Adelaide Jose Vaz
JournalRevista do Instituto de Medicina Tropical de Sao Paulo (Rev Inst Med Trop Sao Paulo) 2004 Nov-Dec Vol. 46 Issue 6 Pg. 303-8 ISSN: 0036-4665 [Print] Brazil
PMID15654474 (Publication Type: Journal Article)
Chemical References
  • Hepatitis C Antibodies
Topics
  • Blood Donors
  • Brazil (epidemiology)
  • Genotype
  • HIV Infections (complications)
  • Hepacivirus (genetics, immunology)
  • Hepatitis C (diagnosis, epidemiology, transmission)
  • Hepatitis C Antibodies (blood)
  • Humans
  • Prevalence
  • Risk Factors
  • Seroepidemiologic Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: